Jamieson Wellness, Inc. (JWEL) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

105.7 k

Shareholding (Mar 2025)

FII

0.00%

Held by 0 FIIs

DII

99.94%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

High Management Efficiency with a high ROCE of 12.41%

Healthy long term growth as Net Sales has grown by an annual rate of 15.70%

Positive results in Jun 25

With ROE of 10.50%, it has a fair valuation with a 3.34 Price to Book Value

Majority shareholders : Mutual Funds

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CAD 1,396 Million (Small Cap)

P/E

30.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.80

Return on Equity

11.17%

Price to Book

2.87

Revenue and Profits:

Net Sales:

199 Million

(Quarterly Results - Jun 2025)

Net Profit:

14 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-12.51%

6 Months

-9.5%

1 Year

-13.37%

2 Years

8.18%

3 Years

-8.26%

4 Years

-19.85%

5 Years

-5.14%

Jamieson Wellness, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Jamieson Wellness Adjusts Valuation Amid Strong Financial Performance and Growth Indicators

Jamieson Wellness, Inc. has recently experienced a valuation adjustment, indicating an improved assessment of its financial health. Key indicators include a P/E ratio of 30, a robust EV to EBIT ratio of 18.61, and a notable annual net sales growth of 15.70%, reflecting strong operational performance.

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

15.34%

EBIT Growth (5y)

9.72%

EBIT to Interest (avg)

7.64

Debt to EBITDA (avg)

2.95

Net Debt to Equity (avg)

0.79

Sales to Capital Employed (avg)

0.79

Tax Ratio

31.59%

Dividend Payout Ratio

64.08%

Pledged Shares

Institutional Holding

0.06%

ROCE (avg)

12.41%

ROE (avg)

11.77%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.15

EV to EBIT

18.61

EV to EBITDA

15.69

EV to Capital Employed

2.18

EV to Sales

2.43

PEG Ratio

0.52

Dividend Yield

ROCE (Latest)

11.71%

ROE (Latest)

10.50%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 1 Schemes (0.06%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 7.74% vs 10.26% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 66.27% vs 15.28% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "199.10",
          "val2": "184.80",
          "chgp": "7.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "28.40",
          "val2": "24.20",
          "chgp": "17.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.90",
          "val2": "6.80",
          "chgp": "-13.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "13.80",
          "val2": "8.30",
          "chgp": "66.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "117.50%",
          "val2": "105.10%",
          "chgp": "1.24%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 8.52% vs 23.53% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 11.09% vs -12.88% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "733.80",
          "val2": "676.20",
          "chgp": "8.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "112.40",
          "val2": "107.70",
          "chgp": "4.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "29.00",
          "val2": "27.60",
          "chgp": "5.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "12.40",
          "val2": "7.90",
          "chgp": "56.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "51.10",
          "val2": "46.00",
          "chgp": "11.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "127.90%",
          "val2": "129.20%",
          "chgp": "-0.13%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

199.10

184.80

7.74%

Operating Profit (PBDIT) excl Other Income

28.40

24.20

17.36%

Interest

5.90

6.80

-13.24%

Exceptional Items

0.00

Consolidate Net Profit

13.80

8.30

66.27%

Operating Profit Margin (Excl OI)

117.50%

105.10%

1.24%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 7.74% vs 10.26% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 66.27% vs 15.28% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

733.80

676.20

8.52%

Operating Profit (PBDIT) excl Other Income

112.40

107.70

4.36%

Interest

29.00

27.60

5.07%

Exceptional Items

12.40

7.90

56.96%

Consolidate Net Profit

51.10

46.00

11.09%

Operating Profit Margin (Excl OI)

127.90%

129.20%

-0.13%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 8.52% vs 23.53% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 11.09% vs -12.88% in Dec 2023

All Annual Results

Company CV

About Jamieson Wellness, Inc.

Jamieson Wellness, Inc.

Pharmaceuticals & Biotechnology

Jamieson Wellness Inc is a Canada-based company, which operates as the health and wellness company. The Company develops, manufactures and markets brand of vitamins and natural health products. The Company offers vitamins, minerals and supplements (VMS) products and certain over-the-counter remedies through Jamieson and LVHS brands, as well as sports nutrition products through Progressive, Precision and Iron Vegan brands. The Company offers manufacturing and product development services on a contract manufacturing basis to select blue-chip consumer health companies and retailers worldwide. Additionally, the Company also offers services to Strategic Partners Business customers, including regulatory advice, new product development and distribution services and industry insights.

Company Coordinates

Company Details

1 Adelaide Street East, Suite 2200 , TORONTO CA : M5C 2V9

Tel: 1 416 96000521 416 7055437

https://investors.jamiesonwellness.com

Registrar Details

Jamieson Wellness, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

MarketsMojo — Loved in India, Now Global

Dashboard

High Management Efficiency with a high ROCE of 12.41%

Healthy long term growth as Net Sales has grown by an annual rate of 15.70%

Positive results in Jun 25

With ROE of 10.50%, it has a fair valuation with a 3.34 Price to Book Value

Majority shareholders : Mutual Funds

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Jamieson Wellness Adjusts Valuation Amid Strong Financial Performance and Growth Indicators

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About Jamieson Wellness, Inc.

Company Coordinates